Ten-Year Experience in the Treatment of Coarctation of the Aorta through Endovascular Stenting in Patients of Different Age Groups

  • Bogdan V. Cherpak National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0002-9956-0432
  • Igor O. Ditkivskyy National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0001-8768-3307
  • Nataliia S. Yashchuk National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0003-1993-5167
  • Yuliia V. Yermolovych National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0001-9723-1339
  • Oleksandr S. Golovenko National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0001-6002-3325
  • Yuriy V. Panichkin National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.30702/ujcvs/21.4512/ChD050-7184
Keywords: coarctation, recoarctation, stenting, grafts, congenital heart disease, pregnant, infants, adolescents

Abstract

The aim. To analyze the 10-year experience in aortic coarctation endovascular stenting in patients of different age groups.

Materials and methods. Examination and endovascular treatment of 194 patients aged 3 days to 60 years with coarctation of the aorta (CoA) with different anatomical and morphological variants was performed. According to the age criterion, the examined patients were divided into 4 study groups. The first group consisted of 84 patients (43.3%) over 25 years of age, group 2 included 33 patients (17.0%) aged 19 to 25 years, group 3 included 71 patients (36.6%) aged 5 to 18 years, and group 4 included 6 patients (3.1%) under 1 year of age.

Results and discussion. We presented the clinical features of different anatomical and morphological variants of CoA. Endovascular treatment of CoA with stenting is considered the best method for adolescents and adults, due to the lower risk of aneurysm formation compared to balloon angioplasty. We were able to successfully reduce the invasive pressure gradient in patients of different ages and to establish the dependence of complication rate on the stent type used. The most common complications were aneurysm formation (2.1%) and stent migration (2.1%). Complications occurred more often in cases of uncovered stents compared to stent grafts (5.3% and 2.1%, respectively, p <0.05). No cases of hospital mortality were recorded in patients older than 5 years. Seven endovascular procedures were performed in 5 patients aged 3 days to 11 months (mean age 3.5 ± 1.6 months) with combined heart defects. Complications were documented in 1 child (20.0%). Endovascular intervention in pregnant women is indicated in refractory hypertension. We performed endovascular CoA stenting in 4 pregnant women at 15–23 weeks of gestation (average, 19.8 ± 3.1 weeks), and in 6 women with well-controlled hypertension stenting was performed within 48 hours to 5 years after delivery. In all the presented cases, successful revascularization was achieved. During follow-up (from 2 months to 10 years), all 10 women are alive, did not develop recoarctation or complications.

Conclusions. The results of the analysis of CoA endovascular treatment showed that the chosen method and technique of intervention is appropriate and safe for patients of all ages, including pregnant women. Based on the results obtained, we have developed an algorithm for the management of patients who, according to clinical examination and echocardiography, were diagnosed with CoA during pregnancy.

References

  1. Lazoryshynets VV, Yemets IM. Istorychni vikhy khirurhii dytiachykh serdets [Milestones in Pediatric Heart Surgery]. Cardiology and cardiac surgery: continuous professional development. 2019;(1):7-11. Ukrainian.
  2. Arfi AM, Galal MO, Kouatli A, Baho H, Abozeid H, al Ata J. Stent angioplasty for critical native aortic coarctation in three infants: up to 15-year follow-up without surgical intervention and review of the literature. Pediatr Cardiol. 2018;39(8):1501-13. https://doi.org/10.1007/s00246-018-1922-8
  3. Assaidi A, Sbragia P, Fraisse A. Transcatheter therapy for aortic coarctation with severe systemic hypertension during pregnancy. Catheter Cardiovasc Interv. 2013;82(4):556-9. https://doi.org/10.1002/ccd.24404
  4. Backer CL, Kaushal S, Mavroudis C. Coarctation of the aorta. In: Mavroudis C, Backer CL, editors. Pediatric cardiac surgery. 4th ed. Hoboken (NJ): Wiley-Blackwell; 2013. p. 256-82.
  5. Balci A, Sollie-Szarynska KM, van der Bijl AG, Ruys TP, Mulder BJ, Roos-Hesselink JW, van Dijk AP, Wajon EM, Vliegen HW, Drenthen W, Hillege HL, Aarnoudse JG, van Veldhuisen DJ, Pieper PG; ZAHARA-II investigators. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100(17):1373-81. https://doi.org/10.1136/heartjnl-2014-305597
  6. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915-57. https://doi.org/10.1093/eurheartj/ehq249
  7. Bentham JR, English K, Ballard G, Thomson JD. Effect of interventional stent treatment of native and recurrent coarctation of aorta on blood pressure. Am J Cardiol. 2013;111(5):731-6. https://doi.org/10.1016/j.amjcard.2012.11.024
  8. Bentham J, Shettihalli N, Orchard E, Westaby S, Wilson N. Endovascular stent placement is an acceptable alternative to reoperation in selected infants with residual or recurrent aortic arch obstruction. Catheter Cardiovasc Interv. 2010;76(6):852-9. https://doi.org/10.1002/ccd.22586
  9. Bhatt AB, Defaria Yeh D. Long-term outcomes in coarctation of the aorta: An evolving story of success and new challenges. Heart. 2015;101(15):1173-5. https://doi.org/10.1136/heartjnl-2015-307641
  10. Bondanza S, Calevo MG, Marasini M. Early and Long-Term Results of Stent Implantation for Aortic Coarctation in Pediatric Patients Compared to Adolescents: A Single CenterExperience.CardiolResPract.2016;2016:4818307. https://doi.org/10.1155/2016/4818307
  11. Brzezinska-Rajszys G. Stents in treatment of aortic coarctation and recoarctation in small children. Int J Cardiol. 2018;263:40-1. https://doi.org/10.1016/j.ijcard.2018.03.141
  12. Chakrabarti S, Kenny D, Morgan G, Curtis SL, Hamilton MC, Wilde P, Tometzki AJ, Turner MS, Martin RP. Balloon expandable stent implantation for native and recurrent coarctation of the aorta--prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart. 2010;96(15):1212-6. https://doi.org/10.1136/hrt.2009.170928
  13. Ciresi CM, Patel PR, Asdell SM, Hopkins KA, Hoyer MH, Kay WA. Management of Severe Coarctation of the Aorta During Pregnancy. JACC Case Rep. 2020;2(1):116-9. https://doi.org/10.1016/j.jaccas.2019.11.060
  14. Dijkema EJ, Leiner T, Grotenhuis HB. Diagnosis, imaging and clinical management of aortic coarctation. Heart. 2017;103(15):1148-55. https://doi.org/10.1136/heartjnl-2017-311173
  15. Eckhauser A, South ST, Meyers L, Bleyl SB, Botto LD. Turner Syndrome in Girls Presenting with Coarctation of the Aorta. J Pediatr. 2015;167(5):1062-6. https://doi.org/10.1016/j.jpeds.2015.08.002
  16. Ewert P, Peters B, Nagdyman N, Miera O, Kühne T, Berger F. Early and mid-term results with the growth stent--a possible concept for transcatheter treatment of aortic coarctation from infancy to adulthood by stent implantation? Catheter Cardiovasc Interv. 2008;71(1):120-6. https://doi.org/10.1002/ccd.21397
  17. Fox EB, Latham GJ, Ross FJ, Joffe D. Perioperative and Anesthetic Management of Coarctation of the Aorta. Semin Cardiothorac Vasc Anesth. 2019;23(2):212-24. https://doi.org/10.1177/1089253218821953
  18. Gewillig M, Budts W, Boshoff D, Maleux G. Percutaneous interventions of the aorta. Future Cardiol. 2012;8(2):251-69. https://doi.org/10.2217/fca.12.10
  19. Hoffman JI. The challenge in diagnosing coarctation of the aorta. Cardiovasc J Afr. 2018;29(4):252-5. https://doi.org/10.5830/CVJA-2017-053
  20. Javed S, Habibi HR. Asymptomatic Coarctation of the Aorta in a Middle-Aged Man; The Significance of Physical Examination. Canadian Journal of General Internal Medicine. 2018;13(1):38-41. https://doi.org/10.22374/cjgim.v13i1.217
  21. Kaya U, Colak A, Becit N, Ceviz M, Kocak H. Surgical Management of Aortic Coarctation from Infant to Adult. Eurasian J Med. 2018;50(1):14-18. https://doi.org/10.5152/eurasianjmed.2017.17273
  22. Kenny D, Hijazi ZM. Coarctation of the aorta: from fetal life to adulthood. Cardiol J. 2011;18(5):487-95. https://doi.org/10.5603/cj.2011.0003
  23. Kipps AK, Olson I, Purkey N, Reddy C. Pediatric Cardiac Acute Care Handbook. 2nd ed. 2018-2019. p. 92-94.
  24. Lee MG, d’Udekem Y. Coarctation of the aorta can no longer be considered a benign condition. Heart Lung Circ. 2014;23(4):297-8. https://doi.org/10.1016/j.hlc.2014.03.001
  25. McElhinney DB, Marshall AC, Schievano S. Fracture of cardiovascular stents in patients with congenital heart disease: theoretical and empirical considerations. Circ Cardiovasc Interv. 2013;6(5):575-85. https://doi.org/10.1161/CIRCINTERVENTIONS.113.000148
  26. Meadows J, Minahan M, McElhinney DB, McEnaney K, Ringel R; COAST Investigators*. Intermediate Outcomes in the Prospective, Multicenter Coarctation of the Aorta Stent Trial (COAST). Circulation. (COAST) 2015;131(19):1656-64. https://doi.org/10.1161/CIRCULATIONAHA.114.013937
  27. Nakamura K, Stefanescu Schmidt A. Treatment of Hypertension in Coarctation of the Aorta. Curr Treat Options Cardiovasc Med. 2016;18(6):40. https://doi.org/10.1007/s11936-016-0462-x
  28. O’BrienP,MarshallAC.Coarctationoftheaorta.Circulation. 2015;131(9):e363-5. https://doi.org/10.1161/CIRCULATIONAHA.114.008821
  29. Punukollu M, Harnden A, Tulloh R. Coarctation of the aorta in the newborn. BMJ. 2011;343:d6838. https://doi.org/10.1136/bmj.d6838
  30. Rao PS. Neonatal (and Infant) Coarctation of the Aorta: Management Challenges. Research and Reports in Neonatology. 2020;10:11-22. https://doi.org/10.2147/RRN.S189545
  31. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group.
  32. ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-241. https://doi.org/10.1093/eurheartj/ehy340
  33. Rogers C, Clawson RE. Coarctation of the aorta.JAAPA. 2019;32(6):46-7. https://doi.org/10.1097/01.JAA.0000558245.81325.02
  34. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on ClinicalPracticeGuidelines.JAmCollCardiol.2019;73(12):81-e192. https://doi.org/10.1016/j.jacc.2018.08.1029
  35. Suradi H, Hijazi ZM. Current management of coarctation of the aorta. Glob Cardiol Sci Pract. 2015;2015(4):44. https://doi.org/10.5339/gcsp.2015.44
  36. Thanopoulos BD, Giannakoulas G, Giannopoulos A, Galdo F, Tsaoussis GS. Initial and six-year results of stent implantation for aortic coarctation in children. Am J Cardiol. 2012;109(10):1499-503. https://doi.org/10.1016/j.amjcard.2012.01.365
  37. Torok RD, Campbell MJ, Fleming GA, Hill KD. Coarctation of the aorta: Management from infancy to adulthood. World J Cardiol. 2015;7(11):765-75. https://doi.org/10.4330/wjc.v7.i11.765
  38. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241-7. https://doi.org/10.1016/j.jacc.2011.08.025
  39. Vergales JE, Gangemi JJ, Rhueban KS, Lim DS. Coarctation of the aorta - the current state of surgical and transcatheter therapies. Curr Cardiol Rev. 2013;9(3):211-9. https://doi.org/10.2174/1573403x113099990032
  40. Vigneswaran TV, Sinha MD, Valverde I, Simpson JM, Charakida M. Hypertension in Coarctation of the Aorta: Challenges in Diagnosis in Children. Pediatr Cardiol. 2018;39(1):1-10. https://doi.org/10.1007/s00246-017-1739-x
  41. Wan AW, Lee KJ, Benson LN. Infolding of covered stents used for aortic coarctation: Report of two cases. Catheter Cardiovasc Interv. 2014;83(1):104-8. https://doi.org/10.1002/ccd.24998
  42. Wong SC, Burgess T, Cheung M, Zacharin M. The Prevalence of Turner Syndrome in Girls Presenting with Coarctation of the Aorta. J Pediatr. 2014 Feb;164(2):259-63. https://doi.org/10.1016/j.jpeds.2013.09.031
Published
2021-12-22
How to Cite
Cherpak, B. V., Ditkivskyy, I. O., Yashchuk, N. S., Yermolovych, Y. V., Golovenko, O. S., & Panichkin, Y. V. (2021). Ten-Year Experience in the Treatment of Coarctation of the Aorta through Endovascular Stenting in Patients of Different Age Groups. Ukrainian Journal of Cardiovascular Surgery, (4 (45), 71-84. https://doi.org/10.30702/ujcvs/21.4512/ChD050-7184
Issue
Ukrainian Journal of Cardiovascular Surgery No 4 (45) 2021
Section
CONGENITAL HEART DEFECTS

Most read articles by the same author(s)